Does mild intrahepatic cholestasis of pregnancy require an aggressive management? Evidence from a prospective observational study focused on adverse perinatal outcomes and pathological placental findings

References

• Gabzdyl EM, Schlaeger JM. Intrahepatic cholestasis of pregnancy: a critical clinical review. J Perinat Neonat Nurs. 2015;29(1):41–50.
   PubMed Web of Science ®Google Scholar
• Ozkan S, Ceylan Y, Ozkan OV, et al. Review of a challenging clinical issue: intrahepatic cholestasis of pregnancy. World J Gastroenterol. 2015;21(23):7134–7141.
   PubMed Web of Science ®Google Scholar
• Floreani A, Gervasi MT. New insights on intrahepatic cholestasis of pregnancy. Clin Liver Dis. 2016;20(1):177–189.
   PubMed Web of Science ®Google Scholar
• Bicocca MJ, Sperling JD, Chauhan SP. Intrahepatic cholestasis of pregnancy: review of six national and regional guidelines. Eur J Obstet Gynecol Reprod Biol. 2018;231:180–187.
   PubMed Web of Science ®Google Scholar
• Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol. 2009;15(17):2049–2066.
   PubMed Web of Science ®Google Scholar
• Ovadia C, Seed PT, Sklavounos A, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses. Lancet. 2019;393(10174):899–909.
   PubMed Web of Science ®Google Scholar
• Labbe C, Delesalle C, Creveuil C, et al. [Early and later intrahepatic cholestasis of pregnancy (ICP): study of adverse pregnancy outcomes]. Gynecol Obstet Fertil Senol. 2018;46(4):388–394.
   PubMed Web of Science ®Google Scholar
• Mei Y, Gao L, Lin Y, et al. Predictors of adverse perinatal outcomes in intrahepatic cholestasis of pregnancy with dichorionic diamniotic twin pregnancies. J Matern Fetal Neonatal Med. 2019;32(3):472–476.
   PubMed Web of Science ®Google Scholar
• Yang J, Chen C, Liu M, et al. Women successfully treated for severe intrahepatic cholestasis of pregnancy do not have increased risks for adverse perinatal outcomes. Medicine (Baltimore). 2019;98(27):e16214.
   PubMed Web of Science ®Google Scholar
• Kohari KS, Carroll R, Capogna S, et al. Outcome after implementation of a modern management strategy for intrahepatic cholestasis of pregnancy. J Matern Fetal Neonatal Med. 2017;30(11):1342–1346.
   PubMed Web of Science ®Google Scholar
• Chappell LC, Chambers J, Dixon PH, et al. Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES). Trials. 2018;19(1):657.
   PubMed Web of Science ®Google Scholar
• Shen Y, Zhou J, Zhang S, et al. Is it necessary to perform the pharmacological interventions for intrahepatic cholestasis of pregnancy? A Bayesian network meta-analysis. Clin Drug Investig. 2019;39(1):15–26.
   PubMed Web of Science ®Google Scholar
• Ovadia C, Lövgren-Sandblom A, Edwards LA, et al. Therapeutic plasma exchange as a novel treatment for severe intrahepatic cholestasis of pregnancy: case series and mechanism of action. J Clin Apher. 2018;33(6):638–644.
   PubMed Web of Science ®Google Scholar
• Estiú MC, Frailuna MA, Otero C, et al. Relationship between early onset severe intrahepatic cholestasis of pregnancy and higher risk of meconium-stained fluid. PLoS One. 2017;12(4):e0176504.
   PubMed Web of Science ®Google Scholar
• Grymowicz M, Czajkowski K, Smolarczyk R. Pregnancy course in patients with intrahepatic cholestasis of pregnancy treated with very low doses of ursodeoxycholic acid. Scand J Gastroenterol. 2016;51(1):78–85.
   PubMed Web of Science ®Google Scholar
• Schumann G, Bonora R, Ceriotti F, et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine. part 4. Reference procedure for the measurement of catalytic concentration of alanine aminotransferase. Clin Chem Lab Med. 2002;40(7):718–724.
   PubMed Web of Science ®Google Scholar
• Schumann G, Bonora R, Ceriotti F, et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International federation of clinical chemistry and laboratory medicine. Part 5. Reference procedure for the measurement of catalytic concentration of aspartate aminotransferase. Clin Chem Lab Med. 2002;40(7):725–733.
   PubMed Web of Science ®Google Scholar
• Tran TT, Ahn J, Reau NS. ACG clinical guideline: liver disease and pregnancy. Am J Gastroenterol. 2016;111(2):176–194.
   PubMed Web of Science ®Google Scholar
•  Royal College of Obstetricians and Gynaecologists. RCOG Green-topGuideline. Vol. 43. Obstetric Cholestasis; April 2011.
   Google Scholar
• Khong TY, Mooney EE, Ariel I, et al. Sampling and definitions of placental lesions: Amsterdam placental workshop group consensus statement. Arch Pathol Lab Med. 2016;140(7):698–713.
   PubMed Web of Science ®Google Scholar
• Burkhardt T, Schäffer L, Schneider C, et al. Reference values for the weight of freshly delivered term placentas and for placental weight-birth weight ratios. Eur J Obstet Gynecol Reprod Biol. 2006;128(1–2):248–252.
   PubMed Web of Science ®Google Scholar
• Redline RW, Heller D, Keating S, et al. Placental diagnostic criteria and clinical correlation - a workshop report. Placenta. 2005;26:S114–S117.
   PubMed Web of Science ®Google Scholar
• Benirschke K. The placenta in the context of history and modern medical practice. Arch Pathol Lab Med. 1991;115(7):663–667.
   PubMed Web of Science ®Google Scholar
• Redline RW. Placental pathology: a systematic approach with clinical correlations. Placenta. 2008;29:S86–S91.
   PubMed Web of Science ®Google Scholar
• Aviram R, T BS, Kidron D. Placental aetiologies of foetal growth restriction: clinical and pathological differences. Early Hum Dev. 2010;86(1):59–63.
   PubMed Web of Science ®Google Scholar
• Redline RW, Minich N, Taylor HG, et al. Placental lesions as predictors of cerebral palsy and abnormal neurocognitive function at school age in extremely low birth weight infants (<1 kg). Pediatr Dev Pathol. 2007;10(4):282–292.
   PubMed Web of Science ®Google Scholar
• Beune IM, Bloomfield FH, Ganzevoort W, et al. Consensus based definition of growth restriction in the newborn. J Pediatr. 2018;196:71.e1–76.e1.
   Web of Science ®Google Scholar
• Gregg AR, Weiner CP. Normal’ umbilical arterial and venous acid–base and blood gas values. Clin Obstet Gynaecol. 1993;36(1):24–32.
   Web of Science ®Google Scholar
• Zhang L, Liu XH, Qi HB, et al. Ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy: a multi-centered randomized controlled trial. Eur Rev Med Pharmacol Sci. 2015;19(19):3770–3776.
   PubMed Web of Science ®Google Scholar